Lastly, the third cohort of 65 early-stage CRC patients helped showcase RKIP expression to be a strong predictor of disease-free survival whereas weak RKIP expression correlated with increased risk of recurrence and shorter disease-free survival [8]. Here, PEBP1 is linked to colorectal carcinoma.